http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Immunosurveillance, immunodeficiencies and lymphoproliferations
lymphoproliferative disorders in congenital and acquired immunodeficiencies
Immunosurveillance, immunodeficiency and lymphoproliferations -- Clinicopathological characteristics of post-transplant lymphoproliferative disorders -- Iatrogenic lymphoproliferative disorders in non-transplantation settings -- The role of Kaposi's Sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases -- Dendritic cells for the induction of EBV immunity -- NF-[kappa]B inhibition in EBV-transformed lymphoblastoid cell lines -- Epstein-Barr viral load as a tool to diagnose and monitor post-transplant lymphoproliferative disease -- The role of immunosuppression in lymphoma -- Identification of prognostic factors in post-transplant lymphoproliferative disorders -- Methods and objectives of a large US multicenter case-control study of post-transplant lymphoproliferative disorder in renal transplant patients -- Antiviral treatment of Epstein-Barr virus-associated lymphoproliferations -- Low-dose chemotherapy for children with post-transplant lymphoproliferative disease -- Engineered antibody for treating lymphoma -- Treatment of post-transplant lymphomas with anti-B-cell monoclonal antibodies -- Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas -- Non-myeloablative stem cell transplantation for congenital immunodeficiencies -- Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma -- Infusional CDE with Rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma : preliminary results of a phase I/II study
Includes bibliographical references and index.